• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于微孔的新型荧光分光光度法和高效液相色谱法与荧光检测法的开发及其高通量用于批量粉末和尿液样品中阿来替尼的定量分析。

Development of Novel Microwell-Based Spectrofluorimetry and High-Performance Liquid Chromatography with Fluorescence Detection Methods and High Throughput for Quantitation of Alectinib in Bulk Powder and Urine Samples.

机构信息

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

出版信息

Medicina (Kaunas). 2023 Feb 23;59(3):441. doi: 10.3390/medicina59030441.

DOI:10.3390/medicina59030441
PMID:36984441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10053830/
Abstract

This study presents the development and validation of the 96-microwell-based spectrofluorimetric (MW-SFL) and high performance liquid chromatography (HPLC) with fluorescence detection (HPLC-FD) methods for the quantitation of alectinib (ALC) in its bulk powder form and in urine samples. The MW-SFL was based on the enhancement of the native fluorescence of ALC by the formation of micelles with the surfactant cremophor RH 40 (Cr RH 40) in aqueous media. The MW-SFL was executed in a 96-microwell plate and the relative fluorescence intensity (RFI) was recorded by utilizing a fluorescence plate reader at 450 nm after excitation at 280 nm. The HPLC-FD involved the chromatographic separation of ALC and ponatinib (PTB), as an internal standard (IS), on a C column and a mobile phase composed of methanol:potassium dihydrogen phosphate pH 7 (80:20, /) at a flow rate of 2 mL min. The eluted ALC and PTB were detected by utilizing a fluorescence detector set at 365 nm for excitation and 450 nm for emission. Validation of the MW-SFL and HPLC-FD analytical methods was carried out in accordance with the recommendations issued by the International Council for Harmonization (ICH) for the process of validating analytical procedures. Both methods were efficaciously applied for ALC quantitation in its bulk form as well as in spiked urine; the mean recovery values were ≥86.90 and 95.45% for the MW-SFL and HPLC-FD methods, respectively. Both methodologies are valuable for routine use in quality control (QC) laboratories for determination of ALC in pure powder form and in human urine samples.

摘要

本研究建立了 96 孔板基质荧光分光光度法(MW-SFL)和高效液相色谱法(HPLC)-荧光检测法(HPLC-FD),用于定量分析原料药阿来替尼(ALC)和尿液中的阿来替尼。MW-SFL 基于 ALC 在水相介质中与表面活性剂聚氧乙烯蓖麻油 RH40(Cr RH40)形成胶束,增强其固有荧光。MW-SFL 在 96 孔板中进行,在 280nm 激发下,利用荧光板读数器记录 450nm 处的相对荧光强度(RFI)。HPLC-FD 涉及 ALC 和泊那替尼(PTB)(作为内标)在 C 柱上的色谱分离,流动相由甲醇:磷酸二氢钾 pH7(80:20,/)组成,流速为 2mL/min。洗脱的 ALC 和 PTB 通过荧光检测器检测,激发波长为 365nm,发射波长为 450nm。MW-SFL 和 HPLC-FD 分析方法的验证按照国际协调委员会(ICH)发布的关于分析程序验证过程的建议进行。两种方法均有效地用于 ALC 原料药的定量分析以及尿液中的加标实验;MW-SFL 和 HPLC-FD 方法的平均回收率分别为≥86.90%和 95.45%。这两种方法都可用于纯粉末形式和人尿液样品中 ALC 的常规 QC 实验室检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/08007ba299c1/medicina-59-00441-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/b6ebc903192a/medicina-59-00441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/b649eb12e3fa/medicina-59-00441-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/825cf11f1e52/medicina-59-00441-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/f2ccc8bbc137/medicina-59-00441-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/68e78623a01e/medicina-59-00441-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/c5c195b95245/medicina-59-00441-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/42a940afd6e0/medicina-59-00441-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/08007ba299c1/medicina-59-00441-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/b6ebc903192a/medicina-59-00441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/b649eb12e3fa/medicina-59-00441-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/825cf11f1e52/medicina-59-00441-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/f2ccc8bbc137/medicina-59-00441-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/68e78623a01e/medicina-59-00441-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/c5c195b95245/medicina-59-00441-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/42a940afd6e0/medicina-59-00441-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4338/10053830/08007ba299c1/medicina-59-00441-g008.jpg

相似文献

1
Development of Novel Microwell-Based Spectrofluorimetry and High-Performance Liquid Chromatography with Fluorescence Detection Methods and High Throughput for Quantitation of Alectinib in Bulk Powder and Urine Samples.基于微孔的新型荧光分光光度法和高效液相色谱法与荧光检测法的开发及其高通量用于批量粉末和尿液样品中阿来替尼的定量分析。
Medicina (Kaunas). 2023 Feb 23;59(3):441. doi: 10.3390/medicina59030441.
2
Development and Comparative Evaluation of Two Different Label-Free and Sensitive Fluorescence Platforms for Analysis of Olaparib: A Recently FDA-Approved Drug for the Treatment of Ovarian and Breast Cancer.开发并比较两种不同的无标记和高灵敏度荧光平台用于奥拉帕利分析:最近 FDA 批准用于治疗卵巢癌和乳腺癌的药物。
Molecules. 2023 Sep 8;28(18):6524. doi: 10.3390/molecules28186524.
3
Development of Novel Micellar-Enhanced High-Throughput Microwell Spectrofluorimetric Method for Quantification of Lorlatinib: Application to In Vitro Drug Release and Analysis of Urine Samples.新型胶束增强高通量微孔荧光分光光度法测定洛拉替尼的方法开发:应用于体外药物释放及尿液样本分析
Pharmaceuticals (Basel). 2023 Sep 6;16(9):1260. doi: 10.3390/ph16091260.
4
Two validated spectrofluorimeteric and high performance liquid chromatography (HPLC) methods with fluorescence detection for the analysis of a new anti-hepatitis C drug, daclatasvir hydrochloride, in raw material or tablet form and in biological fluids.两种经过验证的荧光分光光度法和高效液相色谱法(HPLC),采用荧光检测,用于分析原料药或片剂形式以及生物体液中的新型抗丙型肝炎药物盐酸达拉他韦。
Luminescence. 2018 Dec;33(8):1333-1345. doi: 10.1002/bio.3551. Epub 2018 Oct 23.
5
Development and Validation of HPLC Fluorescence and UPLC/DAD Stability-Indicating Methods for Determination of Hepatitis C Antiviral Agent Daclatasvir.用于测定丙型肝炎抗病毒药物达卡他韦的高效液相色谱荧光法和超高效液相色谱/二极管阵列检测稳定性指示方法的开发与验证
J AOAC Int. 2019 Jul 1;102(4):1125-1131. doi: 10.5740/jaoacint.18-0344. Epub 2019 Apr 2.
6
Dual fluorescence enhancement of loratidine by photoinduced electron transfer blocking and micellization: Application to the development of novel highly sensitive microwell spectrofluorimetric assay for analysis of dosage forms and urine samples.洛拉替丁的光诱导电子转移阻断和胶束化双重荧光增强:用于开发新型高灵敏度微井荧光分析测定法,用于分析剂型和尿液样品。
Spectrochim Acta A Mol Biomol Spectrosc. 2024 Jan 15;305:123458. doi: 10.1016/j.saa.2023.123458. Epub 2023 Sep 26.
7
Response surface methodology for optimization of micellar-enhanced spectrofluorimetric method for assay of foretinib in bulk powder and human urine.胶束强化荧光分光光度法测定福替尼原料药及人尿中福替尼的优化研究
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Aug 5;257:119811. doi: 10.1016/j.saa.2021.119811. Epub 2021 Apr 15.
8
[Determination of eight environmental phenols in human urine samples by high-throughput solid-phase extraction-ultra-performance liquid chromatography-tandem mass spectrometry].[采用高通量固相萃取-超高效液相色谱-串联质谱法测定人尿液样本中的8种环境酚类物质]
Se Pu. 2020 Dec 8;38(12):1456-1464. doi: 10.3724/SP.J.1123.2020.07021.
9
Micellar Enhanced Spectrofluorimetric Method for the Determination of Ponatinib in Human Plasma and Urine via Cremophor RH 40 as Sensing Agent.以聚氧乙烯蓖麻油RH 40为传感剂,采用胶束增敏荧光光谱法测定人血浆和尿液中的波纳替尼。
Int J Anal Chem. 2015;2015:210503. doi: 10.1155/2015/210503. Epub 2015 Dec 31.
10
Stereoselective determination of unchanged and glucuroconjugated eliprodil, a new anti-ischaemic drug, in human plasma and urine by precolumn derivatization and column-switching high-performance liquid chromatography with fluorescence detection.通过柱前衍生化和柱切换高效液相色谱-荧光检测法对新型抗缺血药物埃利罗地及其葡萄糖醛酸共轭物在人血浆和尿液中的立体选择性测定。
J Chromatogr A. 1996 Apr 5;729(1-2):323-33. doi: 10.1016/0021-9673(95)00893-4.

引用本文的文献

1
In Vitro and In Vivo Evaluation of Alectinib-Loaded Dendrimer Nanoparticles as a Drug Delivery System for Non-Small Cell Lung Carcinoma.载阿来替尼树枝状聚合物纳米颗粒作为非小细胞肺癌药物递送系统的体外和体内评价
Pharmaceutics. 2025 Jul 28;17(8):974. doi: 10.3390/pharmaceutics17080974.
2
Chemometrically assisted optimization and validation of the HPLC method for the analysis of alectinib and its related impurity with measurement uncertainty evaluation and whiteness, blueness, and greenness profile assessments.化学计量学辅助的用于分析阿来替尼及其相关杂质的高效液相色谱法的优化与验证,包括测量不确定度评估以及白度、蓝度和绿度轮廓评估。
BMC Chem. 2025 May 28;19(1):147. doi: 10.1186/s13065-025-01509-y.
3

本文引用的文献

1
Response surface methodology for optimization of micellar-enhanced spectrofluorimetric method for assay of foretinib in bulk powder and human urine.胶束强化荧光分光光度法测定福替尼原料药及人尿中福替尼的优化研究
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Aug 5;257:119811. doi: 10.1016/j.saa.2021.119811. Epub 2021 Apr 15.
2
Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma.建立并验证一种液相色谱-串联质谱法检测人血浆中 9 种口服抗癌药物的方法。
J Pharm Biomed Anal. 2019 Sep 10;174:561-566. doi: 10.1016/j.jpba.2019.06.034. Epub 2019 Jun 24.
3
Synthesis of Co/CoO Heterostructure in N-Doped Porous, Amorphous Carbon: A Superior Electrochemical Sensor for Sensitive Determination of Alectinib in Various Fluids.
氮掺杂多孔非晶碳中Co/CoO异质结构的合成:一种用于灵敏测定各种流体中阿来替尼的优异电化学传感器。
ACS Omega. 2024 Oct 24;9(44):44282-44292. doi: 10.1021/acsomega.4c04821. eCollection 2024 Nov 5.
4
Development of Novel Micellar-Enhanced High-Throughput Microwell Spectrofluorimetric Method for Quantification of Lorlatinib: Application to In Vitro Drug Release and Analysis of Urine Samples.新型胶束增强高通量微孔荧光分光光度法测定洛拉替尼的方法开发:应用于体外药物释放及尿液样本分析
Pharmaceuticals (Basel). 2023 Sep 6;16(9):1260. doi: 10.3390/ph16091260.
Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimertinib.
采用液相色谱/三重四极杆质谱法对人血浆中的阿法替尼、阿来替尼、克唑替尼和奥希替尼进行定量分析;重点关注奥希替尼的稳定性。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Apr 15;1113:37-44. doi: 10.1016/j.jchromb.2019.03.011. Epub 2019 Mar 11.
4
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases.阿来替尼治疗间变性淋巴瘤激酶阳性转移性非小细胞肺癌:临床试验证据和脑转移治疗经验。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619831906. doi: 10.1177/1753466619831906.
5
Alectinib (Alecensa)-induced reversible grade IV nephrotoxicity: a case report and review of the literature.阿来替尼(安圣莎)诱发的可逆性IV级肾毒性:一例病例报告及文献综述
J Med Case Rep. 2018 Oct 19;12(1):303. doi: 10.1186/s13256-018-1849-y.
6
Severe Acute Hepatitis in a Patient Receiving Alectinib for ALK-Positive Non-Small-Cell Lung Cancer: Histologic Analysis.一名接受阿来替尼治疗的ALK阳性非小细胞肺癌患者发生的严重急性肝炎:组织学分析
Clin Lung Cancer. 2019 Jan;20(1):e77-e80. doi: 10.1016/j.cllc.2018.09.006. Epub 2018 Sep 21.
7
LC-MS/MS determination of alectinib and its major human metabolite M4 in human urine: prevention of nonspecific binding.液相色谱-串联质谱法测定人尿液中的阿来替尼及其主要人体代谢物M4:防止非特异性结合。
Bioanalysis. 2017 Mar;9(5):459-468. doi: 10.4155/bio-2016-0284. Epub 2017 Feb 8.
8
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.两项针对ALK阳性非小细胞肺癌经治患者的研究中,中枢神经系统对阿来替尼反应的汇总分析。
J Clin Oncol. 2016 Dec;34(34):4079-4085. doi: 10.1200/JCO.2016.68.4639. Epub 2016 Oct 31.
9
An UPLC-MS/MS method for the quantitation of alectinib in rat plasma.一种用于定量大鼠血浆中阿来替尼的超高效液相色谱-串联质谱法。
J Pharm Biomed Anal. 2017 Jan 5;132:227-231. doi: 10.1016/j.jpba.2016.10.010. Epub 2016 Oct 14.
10
Bioanalysis of alectinib and metabolite M4 in human plasma, cross-validation and impact on PK assessment.人血浆中阿来替尼及其代谢物M4的生物分析、交叉验证及对药代动力学评估的影响。
Bioanalysis. 2016 Jul;8(14):1465-79. doi: 10.4155/bio-2016-0068. Epub 2016 Jun 22.